Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.85)
# 1,824
Out of 5,072 analysts
2
Total ratings
100%
Success rate
29.64%
Average return

Stocks Rated by Patrick Dolezal

Kodiak Sciences
Oct 23, 2025
Initiates: Outperform
Price Target: $40
Current: $22.44
Upside: +78.25%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Outperform
Price Target: $17$26
Current: $21.40
Upside: +21.50%